Stetler D A, Jacob S T
J Biol Chem. 1984 Jun 10;259(11):7239-44.
Poly(A) polymerases purified from rat liver nuclei consisted of two distinct species, a predominant enzyme of Mr = 38,000 and a minor one of Mr = 48,000. Prior to extensive purification, the minor enzyme constituted approximately 1% of the total liver poly(A) polymerase. Poly(A) polymerase purified from a rat tumor, Morris hepatoma 3924A, was comprised of a single species of Mr = 48,000 which was identical to the minor liver enzyme with respect to chromatographic and immunological characteristics. Gel filtration on Sephacryl S-200 using 0.3 M NaCl for elution showed that the major liver poly(A) polymerase had a molecular weight of 156,000, which corresponded to a tetramer of the 38-kDa polypeptide, whereas the hepatoma and minor liver 48-kDa species existed as dimers with a molecular weight of 96,000. Fractionation by Sephacryl S-200 resulted in complete loss of both liver poly(A) polymerase activities which could be restored by exogenous N1-type protein kinase. Following CNBr cleavage, the 48-kDa poly(A) polymerase from liver and hepatoma exhibited nearly identical peptide maps which were distinct from that of the major liver enzyme (38 kDa). Antibodies raised against tumor poly(A) polymerase reacted with the 48-kDa polypeptide but not with the 38-kDa liver enzyme. Immune complex formation was observed between seven of the eight CNBr cleavage products derived from the 48-kDa polypeptide of both liver and hepatoma. It is concluded that distinct genes in rat liver code for two structurally and immunologically unique nuclear poly(A) polymerases, one of which is identical to the enzyme from the hepatoma.
从大鼠肝细胞核中纯化得到的聚腺苷酸聚合酶由两种不同的类型组成,一种主要的酶分子量为38,000,另一种次要的酶分子量为48,000。在进行广泛纯化之前,次要的酶约占肝脏总聚腺苷酸聚合酶的1%。从大鼠肿瘤——莫里斯肝癌3924A中纯化得到的聚腺苷酸聚合酶由单一的分子量为48,000的类型组成,就色谱和免疫学特性而言,它与肝脏中的次要酶相同。使用0.3M氯化钠进行洗脱,在Sephacryl S - 200上进行凝胶过滤显示,肝脏中的主要聚腺苷酸聚合酶分子量为156,000,相当于38 kDa多肽的四聚体,而肝癌和肝脏中的次要48 kDa类型以分子量为96,000的二聚体形式存在。通过Sephacryl S - 200分级分离导致肝脏聚腺苷酸聚合酶的两种活性完全丧失,而外源性N1型蛋白激酶可以使其恢复。经溴化氰裂解后,来自肝脏和肝癌的48 kDa聚腺苷酸聚合酶表现出几乎相同的肽图,这与主要的肝脏酶(38 kDa)的肽图不同。针对肿瘤聚腺苷酸聚合酶产生的抗体与48 kDa多肽反应,但不与38 kDa的肝脏酶反应。在源自肝脏和肝癌的48 kDa多肽的八个溴化氰裂解产物中的七个之间观察到免疫复合物的形成。得出的结论是,大鼠肝脏中的不同基因编码两种结构和免疫学上独特的核聚腺苷酸聚合酶,其中一种与来自肝癌的酶相同。